Iron

3

Review clinical trials related to Iron. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

IRONCARE: Iron Treatment in Older Patients With Hip Fractures

The aim of this study is to investigate the effects of intravenous (IV) iron therapy compared to alternate-day oral iron treatment and no supplementation in older patients with hip fractures. This study will examine the impact of iron treatment on fatigue, functional decline, fear of falling, cognitive impairment, and quality of life, as well as its effects on iron stores and hemoglobin levels, with the overall goal of improving postoperative rehabilitation. The trial will be conducted on five different hospitals in the Central Region of Denmark (Region Midtjylland).

Participants needed: 528
Trial details
Phase: Phase 4Age: 75+Biological sex: AllType: InterventionalSponsor: University of AarhusUpdated: Jun 24, 2026Locations: 5
Eligibility criteria

Hip fracture (ICD-10 codes: DS720, DS721 and DS722) [+3]

Pathological fracture [+10]

Status: Recruiting

A Study on the Correlation Between Tear Iron Levels and the Severity of Dry Eye Disease.

This study aims to see if the amount of iron in tears is linked to how severe dry eye disease is. We hope this can lead to a new way to help diagnose and understand dry eye. This is an observational study. We will compare tear samples from people with dry eye to samples from people with healthy eyes. We will measure the iron content in the tears and see if it correlates with standard dry eye test results and symptom scores.

Participants needed: 52
Trial details
Age: 18-70Biological sex: AllType: ObservationalSponsor: Shanghai Changzheng HospitalUpdated: Feb 10, 2026Locations: 1
Eligibility criteria

Aged between 18 and 70 years, inclusive. [+1]

History or clinical suspicion of significant systemic conditions: hematologic di... [+7]

Status: Recruiting

Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders

This is a prospective, single-arm, single-center observational study evaluating the impact of intravenous (IV) iron replacement in patients with inherited bleeding disorders and iron deficiency (ferritin \<50ng/dL). Subjects will undergo baseline bleeding assessments, quality-of-life measures, and laboratory tests before receiving standard-of-care IV iron. Follow-up blood work and questionnaires will be conducted post-replacement to assess for changes

Participants needed: 40
Trial details
Age: 15+Biological sex: AllType: ObservationalSponsor: Nicoletta C MachinUpdated: Oct 3, 2025Locations: 1
Eligibility criteria

Males and Females > 15 years of age [+5]

Previous thrombosis, VTE History. [+2]